A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

The findings showed that fitusiran lowers antithrombin levels to enhance thrombin generation and restore hemostasis in ...

Vinh Le ’24 announces Dr. Cushman’s mentoring award at the American Heart Association EPI conference Cushman is University ...

Prima Medicine is proud to announce the addition of Dr. Mandana Shafai to its esteemed team of medical professionals. Dr. Shafai joins the practice as a Concierge Medicine Physician, bringing with her ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: Good afternoon ladies and gentlemen and thank you for standing by.

Expanding access to the Nu.Q Vet cancer test is one of Volition's primary objectives ... and the International Society for Thrombosis and Hemostasis in Q2 alone. There are other conferences ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

The following is a summary of “Reversal of Factor Xa Inhibitor-Related Intracranial Hemorrhage: A Multicenter, Retrospective, Observational Study Comparing the Efficacy and Safety of Andexanet and ...

Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market” with a primary focus on the present and ...